HiSiaddi is an innovative foreign trade service provider driven by dual engines of technology transformation and foreign trade services. We have established a "1+2+3+4=1" service system and can supply raw materials of Coriolus Versicolor Extract from multiple well-known original manufacturers.
With over a decade of market experience and technological cooperation with manufacturers, HiSiaddi possesses extensive expertise in product compliance issues. Below is a case study of HiSiaddi’s resolution of compliance challenges for Coriolus Versicolor Extract.
Please contact HiSiaddi customer service if you require further consultation on Coriolus Versicolor Extract product compliance issues.
The buyer is Nexus Wellness INC, headquartered in California, USA — a leading mid-to-high-end dietary supplement enterprise in North America with products sold at Whole Foods supermarkets nationwide, premium private wellness clinics and chain organic pharmacies. Its flagship products are high-purity Coriolus Versicolor Polysaccharide Capsules and post-operative rehabilitation dietary powders. Raw materials comply with U.S. FDA dietary supplement regulations, NDI (New Dietary Ingredient) filings, USP <232/233> heavy metal limits, EU EC396 regulation covering 226 pesticide residue items and California Proposition 65. The enterprise plans to procure 11.5 tons of pharmaceutical-grade Coriolus Versicolor Extract annually, with mandatory indicators: total polysaccharides ≥32%, quantitatively labeled PSP/PSK components, 100% forest-grown fruiting body raw materials, no added exogenous auxiliary materials.
The client independently sourced samples and pre-production inventory from three domestic plant extract manufacturers at the early stage, yet four critical compliance blockages emerged shortly before shipment: lack of NDI filings preventing U.S. customs clearance, pesticide residue and heavy metal test results approaching FDA limits, absence of FDA dietary GMP registration for manufacturers, and non-compliant Chinese-English labels. An initial 3.2 tons of semi-finished products were stranded at the factory unable to ship. Switching to raw materials sourced from European and American local suppliers would raise procurement costs by 42% and delay lead times by 90 days, putting the client’s new product launch plan at risk of cancellation. The client fully entrusted HiSiaddi to coordinate full-dimensional compliance rectification.
Coriolus Versicolor Extract is classified as a New Dietary Ingredient under U.S. FDA regulations, requiring a 75-day advance NDI filing notification prior to import clearance. The three original suppliers only held domestic SC food production qualifications without completing NDI documentation for Coriolus Versicolor raw materials or FDA acceptance receipts. Shipments would be automatically detained under DWPE procedures upon arrival at U.S. ports with full container rejection and scrappage. The client was unfamiliar with U.S. dietary raw material access rules and mistakenly assumed domestic qualifications would suffice for customs clearance.
Previous manufacturers mixed greenhouse rapid-cycle fungi with forest-grown raw materials without standardized GACP field cultivation ledgers. Pesticide residue and lead/cadmium indicators for partial batches hovered at EU regulatory critical values; SGS external test reports covered incomplete test items and adopted testing methods inconsistent with official USP standards, rendering report data inadmissible by European and American customs. Complete gaps existed in raw material origin traceability documents and pesticide application records, with previous similar product alerts logged in the EU RASFF warning system.
Imported dietary raw materials for the U.S. market require manufacturers to complete FDA Food Facility Registration (FFR) and adhere to 21CFR Part 111 dietary GMP standards. Original manufacturers only held domestic SC certificates without overseas registration files, enabling the FDA to order full-container return shipments solely based on unqualified factory qualifications.
Product outer carton labels provided by manufacturers included efficacy descriptions such as "boost immunity, assist chronic disease improvement", which qualify as drug claims under U.S. regulations and exceed permitted labeling scope for dietary supplements. Label formatting for allergen prompts, fungal source statements, net weight and disclaimers failed to comply with U.S. labeling code requirements, failing customs label verification.
HiSiaddi assembled a special team of overseas regulatory specialists, plant extract quality control engineers and third-party testing coordinators to close compliance gaps across four dimensions: filings, raw materials, production lines and labels, implemented in four phases: sample retesting, production line rectification, qualification supplementation and document archiving.
1. Compile standardized NDI filing dossiers per FDA format, including Coriolus Versicolor Latin nomenclature, raw material source, extraction processes, toxicological literature and domestic & overseas safe consumption history data;
2. Submit NDI declarations online via the FDA official COSM system, track the full 75-day public review cycle and successfully obtain FDA acceptance receipts and filing numbers to secure legal import qualifications for raw materials;
3. Supplement California Proposition 65 chemical substance disclosure dossiers simultaneously to mitigate compliance inspection risks at California ports.
1. Eliminate the three original manufacturers with unregulated raw material control and switch to compliant manufacturers with designated Changbai Mountain forest harvest bases and GACP cultivation standards, signing raw material traceability agreements. Each batch is accompanied by origin certificates, field pesticide application ledgers and harvest records;
2. Commission ISO17025-accredited Eurofins laboratories to conduct full-item testing covering 226 pesticide residues and heavy metals under dual USP and EC396 standards, strictly controlling lead <1.5 ppm and cadmium <0.3 ppm. All batches exceeding limits are reworked with new feedstock; finished product COA certificates adopt testing methods recognized by Europe and America uniformly;
3. Supplement MSDS safety data sheets and microbial limit test reports simultaneously to compile full sets of customs compliance documents.
1. Support partner manufacturers in submitting FDA Food Facility Registration (FFR) to obtain official FDA factory registration codes;
2. Optimize workshop clean zoning, raw material warehousing and full-process production quality control records per 21CFR Part 111 dietary GMP standards, complete batch production records (BPR) and batch inspection records, and organize full GMP system documentation to prepare for unannounced FDA factory audits.
1. Delete all disease-related efficacy descriptions and replace them with standard dietary supplement wording permitted by the FDA, with mandatory FDA disclaimers uniformly printed: This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease;
2. Standardize labeling of raw material sources, fungal allergen warnings, net weight and overseas agent information for manufacturers, calibrate label layouts line-by-line against U.S. code requirements, and archive finalized label drafts for filing.
After 58 days of full-process compliance rectification, NDI filings were successfully completed, all sample batches passed full-item testing in one round, manufacturer FDA registration and GMP documentation were fully supplemented, and label reviews were approved. The previously stranded 3.2 tons of semi-finished products completed rectification and shipped from Shanghai Port to Los Angeles, passing random FDA port inspections, label verification and document reviews for one-time customs clearance and warehousing with no detention or on-site rectification orders.
The client finalized a long-term annual procurement framework for 11.5 tons scheduled for monthly production across 10 batches. Supported by complete compliance qualifications, the Coriolus Versicolor raw materials successfully landed shelf space at all Whole Foods retail channels, enabling the client’s new product to launch as scheduled. Compared with raw materials sourced from local European and American manufacturers, overall procurement costs decreased by 31.2%, and sea freight lead time was shortened from 90 days to 23 days. In the subsequent year, the client added demand for organic-certified Coriolus Versicolor Extract, with HiSiaddi coordinating dual U.S. USDA Organic and EU Organic compliance certification for sustained in-depth cooperation.
Most domestic plant extract manufacturers focus on the domestic market and lack awareness of U.S. regulations including NDI filings, FDA factory registration and California Proposition 65, only capable of providing domestic qualification documents. Mid-to-high-end North American dietary brands are proficient in stringent local drug administration regulations yet lack understanding of severe unevenness in factory qualifications and disconnected compliance systems between Chinese raw material manufacturers and European/American standards. Independent direct sourcing frequently traps buyers in four overlapping compliance pitfalls: missing filings, non-compliant testing results, unqualified factory certifications and non-compliant labels.
Leveraging cross-border regulatory resources and accumulated plant extract industry expertise, HiSiaddi provides one-stop full-chain compliance gap remediation, breaking down compliance barriers for high-end domestic Coriolus Versicolor Extract to enter North America’s mid-to-high-end dietary supplement supply chain.
Please contact HiSiaddi customer service if you require further consultation on Coriolus Versicolor Extract product compliance issues.
+86-13120989737 
info@hisiaddi.com 
English
